From the NIH directors blog, Francis Collins just issued a statement on the NIH stance toward gene editing on human embryos:
NIH will not fund any use of gene-editing technologies in human embryos. The concept of altering the human germline in embryos for clinical purposes has been debated over many years from many different perspectives, and has been viewed almost universally as a line that should not be crossed. Advances in technology have given us an elegant new way of carrying out genome editing, but the strong arguments against engaging in this activity remain. These include the serious and unquantifiable safety issues, ethical issues presented by altering the germline in a way that affects the next generation without their consent, and a current lack of compelling medical applications justifying the use of CRISPR/Cas9 in embryos.
This comes in response to a Chinese group who has used the CRISPR/Cas9 system to delete a gene from human embryos that causes a fatal blood disorder. There has been quite a bit of controversy on this new technique, which has led to the developers of the CRISPR/Cas9 system to call for a moratorium. Read the full statement from the NIH director here.
CauseScience would love to hear your thoughts on this new technology! Do we need to control the usage of this gene editing technology? Are scientists pushing the technology too fast without considering ethical implications? Is gene editing ethical? Comment or tweet @CauseScience1